PwC expands AI capabilities to help accelerate transparency reporting

27/01/26

Example pattern for mobile
Example pattern for desktop

Emily Singh

Principal, Pharmaceutical and Life Sciences, PwC US

Email

PwC is expanding its AI capabilities to support pharmaceutical and life sciences organizations facing increasingly complex transparency reporting requirements. As invoice volumes grow and expectations for speed, accuracy, and auditability rise, manual invoice review can slow reporting cycles and increase compliance risk. PwC’s advanced document intelligence helps managed service teams to automate invoice review at scale—ultimately helping our clients achieve faster, more consistent, and audit-ready transparency reporting outcomes.

The AI-driven capability automates the multilingual extraction and consolidation of key invoice data required for transparency reporting, including HCP and HCO identifiers, payment amounts, service descriptions, and transaction dates. By reducing reliance on manual data parsing, PwC teams can process invoices up to 60–70% faster, reduce manual review effort by up to 80%, and improve data accuracy by up to 30%—strengthening reporting quality and reducing downstream rework.

Powered by an LLM-driven workflow with smart search, customized prompting, and bulk ingestion, the capability supports the simultaneous processing of thousands of invoices while maintaining auditability and governance. This enables transparency programs to scale efficiently as volumes increase and regulations evolve.

What this delivers for clients

  • Faster transaction remediation
    AI-driven automation reduces invoice processing time by up to 70%, helping organizations meet regulatory deadlines with confidence.
  • Significant reduction in manual effort
    Automated extraction and review can reduce manual hours by up to an estimated 80%
  • Improved data accuracy and consistency
    Standardized multilingual parsing supports estimated accuracy improvements of up to 30%
  • Scalable, high-volume processing
    Bulk ingestion enables simultaneous processing of thousands of invoices as transparency obligations expand.
  • Greater focus on oversight and quality
    Automation frees teams to focus on quality checks, issue resolution, and proactive client support.

By combining AI-driven automation, governance, and deep domain expertise, PwC continues to enhance transparency reporting for pharmaceutical and life sciences organizations—supporting accurate, audit-ready outcomes at scale.

Next and previous component will go here

Follow us